{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSESOP-2008 SOP BCG administration 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "ADMINISTRATION OF BCG FOR HEALTH CARE WORKERS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSESOP-2008"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "SOP"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Occupational Health staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "19 October 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "18 October 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "National Guidance/Recommendations NICE (2019) Tuberculosis NG33 DOH (2013) Immunisation against infectious diseases \u2013 The Green Book (TB chapter 32 updated 2018)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "HR/ Occupational Health"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Teresa Dowdeswell, Occupational Health Advisor/ Site Lead, Southend"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2612 Basildon Hospital \u2612 Broomfield Hospital \u2612 Southend Hospital \u2612 Other (please state) \u2013 external contracts as required"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Site Lead Nurses Group (OH)"
                    },
                    {
                        "text": "14 September 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Kelly McClenaghan, Interim AD Head of Occupational Health and Wellbeing"
                    },
                    {
                        "text": "14 September 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "06 October 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "September 20"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSESOP-2008 SOP BCG administration 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Kelly McClenaghan, Angela Hyman"
                    },
                    {
                        "text": "Site Leads, OH"
                    },
                    {
                        "text": "11 August 2020"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Infection Control Lead"
                    },
                    {
                        "text": "24 August 2020"
                    },
                    {
                        "text": "Simon Worrell"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "24 August 2020"
                    },
                    {
                        "text": "Dr Leighton"
                    },
                    {
                        "text": "Occupational Health Physician"
                    },
                    {
                        "text": "24 August 2020"
                    },
                    {
                        "text": "Jennie Keane"
                    },
                    {
                        "text": "TB nurse specialist"
                    },
                    {
                        "text": "24 August 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Staff Screening and Immunisation Policy Infection Control Policy TB Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Teresa Dowdeswell"
                    },
                    {
                        "text": "New SOP"
                    },
                    {
                        "text": "19 October 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Key Elements of Policy / Guideline ............................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Training Requirements ............................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Monitoring and Audit ................................................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Approval and Implementation ..................................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Equality Impact Assessment ....................................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "References ................................................................................................................. 11 Appendix 1: Preliminary Equality Analysis ......................................................................... 13"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The BCG is the only vaccine available against Tuberculosis (TB)."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "People in the following occupational groups with direct TB patient contact or contact with infectious materials should be vaccinated with BCG:"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health care worker (HCW) or laboratory worker, who has either direct or contact with TB patients or with potentially infectious clinical materials or derived isolates."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "This SOP should be read in conjuction with the recommendations in the current British National Formulary, The Green Book, Chapter 32, and the description of the individual product contained within the product packaging. This protocol should be read in conjunction with the Tuberculosis Policy."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To provide clarification on HCW's eligible for BCG vaccination"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To outline procedures for vaccinators to follow."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "type": "table",
            "sequence_num": 27,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "BCG"
                    },
                    {
                        "text": "Bacille de Calmette et Guerin (BCG) vaccination."
                    },
                    {
                        "text": "HCW"
                    },
                    {
                        "text": "Health Care Workers"
                    },
                    {
                        "text": "OH"
                    },
                    {
                        "text": "Occupational Health"
                    },
                    {
                        "text": "TB"
                    },
                    {
                        "text": "Tuberculosis"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Key Elements of Policy / Guideline"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Prior to Vaccination \u2013 The OH immunisation nurse will arrange for appropriate staff to be invited to receive the vaccination. A vaccination history and BCG scar check is obtained from the employee to determine suitability. A Mantoux test should have been undertaken prior to administration of the BCG. See SOP for Tuberculin Skin Testing (Mantoux)."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Recommended Groups for Vaccination \u2013 HCW or laboratory worker who has either direct contact with TB patients or with potentially infectious clinical materials or derived isolates."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Immunisation Process"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "type": "table",
            "sequence_num": 32,
            "data": {
                "num_rows": 6,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "BCG Immunistion"
                    },
                    {
                        "text": "The vaccine is a freeze-dried powder for suspension for injection. BCG Vaccine AJV is supplied in a glass vial containing the equivalent of 10 adult or 20 infant doses, fitted with a bromobutyl rubber stopper which does not contain latex. The powder must be reconstituted with 1ml of the diluted Sauton AJV diluent which is supplied separately."
                    },
                    {
                        "text": "Storage"
                    },
                    {
                        "text": "Store at +2\u00b0C to +8\u00b0C"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "for further advice."
                    },
                    {
                        "text": "Contra- indications"
                    },
                    {
                        "text": "The vaccine should not be given to: Those who have already had a BCG vaccination Those with a past history of TB Those with an induration of 5mm or more following Mantoux tuberculin skin testing those who are receiving, or have received in the past 6 months, immunosuppressive chemotherapy or radiotherapy for malignant disease or non-malignant disorders immunosuppressive therapy for a solid organ transplant (with exceptions, depending upon the type of transplant and the immune status of the patient) those who are receiving or have received in the past 12 months immunosuppressive biological therapy (e.g. anti-TNF therapy such as alemtuzumab, ofatumumab and rituximab) unless otherwise directed by a specialist those who are receiving or have received in the past 3 months immunosuppressive therapy including: Adults and children on high-dose corticosteroids (>40mg prednisolone per day or >2mg/kg/day in children under 20kg) for more than 1 week Adults and children on lower dose corticosteroids"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 33,
            "data": {
                "num_rows": 9,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "(>20mg prednisolone per day or >1mg/kg/day in children under 20kg) for more than 14 days non-biological oral immune modulating drugs e.g. methotrexate >25mg per week, azathioprine >3.0mg/kg/day or 6-mercaptopurine >1.5mg/kg/day for children on non-biological oral immune modulating drugs (except those on low dose) specialist advice should be sought prior to vaccination BCG vaccine is absolutely contraindicated in all HIV-positive persons"
                    },
                    {
                        "text": "Precautions"
                    },
                    {
                        "text": "Minor illness without fever or systemic upset is not a valid reason to postpone immunisation. If an individual is acutely unwell, immunisation maybe postponed until they have fully recovered"
                    },
                    {
                        "text": "Clients with generalised septic skin conditions should not be vaccinated. Chose an immunisation site free from skin lesions."
                    },
                    {
                        "text": "Not to be given during pregnancy. Check the Green Book chapter 32 re breastfeeding."
                    },
                    {
                        "text": "Reconstituting the BCG vaccine AJV"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "BCG vaccine AJV information leaflet after care instructions anaphylactic pack Diluted Sauton AJV Solvent and BCG vaccine AJV Syringe long needle and syringe for drawing up and adding solvent to BCG vaccine vial 1ml graduated syringe or tuberculin syringe 26G 10mm (0.45mm x 10mm)short bevelled needle for intradermal injection Cytotoxic (purple lidded) sharps bin"
                    },
                    {
                        "text": "Check label for correct Diluted Sauton Solvent Check expiry date Remove blue cap Draw up the solvent to reconstitute the BCG vaccine Do not use any other solution to reconstitute the BCG vaccine, as these may damage the vaccine."
                    },
                    {
                        "text": "Check the label for correct BCG vaccine Check expiry date"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 34,
            "data": {
                "num_rows": 6,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Remove blue cap Gently add the diluent into the vial of BCG vaccine The powder in the dark amber vial is white and crystallised, the powder might be difficult to see due to the small amount of powder in the vial"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Gently invert the vial a few times to resuspend the lyophilised BCG completely Do not shake the vial Gently swirl the vial with reconstituted vaccine before drawing up each subsequent dose Do not shake the vial as this can affect the potency of the vaccine."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "When drawn up into the syringe the reconstituted vaccine should appear homogeneous, slightly opaque and colourless using the syringe with the long needle draw up the required dose of reconstituted vaccine. Draw the volume in the needle back into the syringe before removing the needle so when the needle is changed to the short bevelled needle there is sufficient vaccine to prime the needle leaving the correct dose for administration"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Attach firmly the short bevelled needle to the syringe containing the reconstituted vaccine Prime the needle to the require dose ready to administer the vaccine through the intradermal technique"
                    },
                    {
                        "text": "Intradermal Administration of BCG Vaccination"
                    },
                    {
                        "text": "The intradermal technique is the most accurate method of administration because the dose can be measured precisely and the administration can be controlled , it also ensures that adverse reactions are minimised The type of syringe and needle size is important to ensure correct administration of the intradermal injection (jet injectors and multiple puncture devices should not be used)"
                    },
                    {
                        "text": "Intradermal technique"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 35,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "BCG vaccine is administered strictly intradermally normally into the lateral aspect of the left upper arm at the level of the insertion of the deltoid muscle (just above the middle of the left upper arm (recommended by WHO) The upper arm should be positioned approximately 45\u02da to the body This can be achieved in older children and adults if the hand is placed on the hip with the arm abducted from the body Sites higher on the arm, and particularly the tip of the shoulder are more likely to lead to keloid formation and should be avoided"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "It is not necessary to disinfect the skin. If the skin is visibly dirty it should be washed with soap and water."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "The interdermal injection is administered with the bevel facing up. With the bevel upwards, the needle is slowly insert about 3mm into the superficial layers of the dermis almost parallel with the surface The needle can usually be seen through the dermis A correctly given intradermal injection results in a tense, blanched, raised bleb, and considerable resistance is felt when the fluid is being injected A bleb is typically of 7mm diameter following a 0.1ml intradermal injection, and 3mm following a 0.05ml intradermal injection If little resistance is felt when injecting and a diffuse swelling occurs as opposed to a tense blanched bleb, the needle is too deep the needle should be withdrawn and reinserted intradermally before more vaccine is given"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 36,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Disposal"
                    },
                    {
                        "text": "BCG vaccine waste should be disposed of in accordance with the recommendations for waste classified as potentially cytotoxic / cytostatic Equipment used for immunisation, including used vials, ampoules, or discharged vaccines in a syringe, should be disposed of safely in a UN-approved puncture-resistant \u2018sharps' box, according to local authority regulations and guidance in the technical memorandum 07- 01: Safe management of healthcare waste (Department of Health, 2013)."
                    },
                    {
                        "text": "Aftercare"
                    },
                    {
                        "text": "The client should be given an aftercare leaflet. The expected reaction to successful BCG vaccination, seen in 90 to 95% of recipients, is induration at the injection site followed by a local lesion which starts as a papule two or more weeks after vaccination The local lesion may ulcerate and then slowly subside over several weeks or months to heal, leaving a small, flat scar it is not necessary to protect the site from becoming wet during washing and bathing the injection site is best left uncovered to facilitate healing the ulcer should be encouraged to dry, and abrasion (by tight clothes, for example) should be avoided should any oozing occur, a temporary dry dressing may be used until"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 37,
            "data": {
                "num_rows": 5,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "a scab forms. It is essential that air is not excluded if absolutely essential (e.g. to permit swimming), an impervious dressing may be used but it should be applied only for a short period as it may delay healing and cause a larger scar the possibility of bacterial superinfection in a discharging lesion should be considered Further observation after routine vaccination with BCG is not necessary, other than as part of monitoring of the quality of the programme, nor is further tuberculin testing recommended no further immunisation should be given in the arm used for BCG immunisation for at least three months because of the risk of regional lymphadenitis"
                    },
                    {
                        "text": "Documentation"
                    },
                    {
                        "text": "Client cohort record to state: Due date Date of administration Dose Batch number Method of administration (ie intradermal) Site of administration Consent obtained Consent type Contraindication to vaccine (yes/no) Employment Type of employment (i.e. current) Name of administering nurse"
                    },
                    {
                        "text": "Adverse effects"
                    },
                    {
                        "text": "Common: pain, irritation or discomfort at the injection site immediately after the injection. Uncommon: headache, fever or enlargement of regional lymph nodes."
                    },
                    {
                        "text": "Rare: vesiculation, skin necrosis and urticaria."
                    },
                    {
                        "text": "Very rare: hypersensitivity including anaphylactic reactions."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Staff should complete the on line immunisation training (PHE) on BCG and provide certificate of completion. Should shadow a competent practitioner."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Staff  should  be  deemed  competent  by  their  Site  Lead  following  competency assessment."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Outlined  below  is  the  Trust's  process  of  monitoring  compliance  with,  and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "type": "table",
            "sequence_num": 43,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Compliance to vaccination"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "OH"
                    },
                    {
                        "text": "6 monthly"
                    },
                    {
                        "text": "Occupational Health Group Managers of relevant departments"
                    },
                    {
                        "text": "AD for Occupational Health and Wellbeing"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "All policies, procedures and guidelines will be approved by the senior nurse group within OH ,  which  is  the  specialist  group  with  the  authority  to  approve  local standard  operating  procedures.  These  will  then  be  forwarded  to  the Document  control  team  for  submission  and  ratification  by  the  Joint  Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "It  is  the  author's  responsibility  to  inform  the  Associate  Director  of Occupational Health and Wellbeing and OH team of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health (2013) Immunisation Against Infectious Diseases. Available from: https://www.gov.uk/government/collections/immunisation-against-infectious- disease-the-green-book"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NICE (2019) Tuberculosis (NG33)Available from: https://www.nice.org.uk/guidance/ng33/chapter/Recommendations#preventing-tb"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England (2018). BCG Vaccine AJV:training slide set for healthcare professionals. Available from: https://publichealthengland-immunisati.app.box.com"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England/ Royal College of Nursing (2018) National Minimum standards and core curriculum for immunisation training for registered health practitioners. Available from: https://www.gov.uk/government/publications/national- minimum-standards-and-core-curriculum-for-immunisation-training-for-registered- healthcare-practitioners"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration of BCG to Health Care Workers / MSESOP-2008 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration of BCG to Health Care Workers / MSESOP-2008 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Appendix : Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Administration of BCG to Health Care Workers / MSESOP-2008: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "type": "table",
            "sequence_num": 60,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 61,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Administration of BCG using a licenced product."
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To afford protection to staff who are exposed to TB"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff are protected from TB."
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 62,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Teresa Dowdeswell"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Occupational Health Advisor Site Lead Southend"
                    },
                    {
                        "text": "24 August 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 64
        }
    ]
}